+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Paediatric Healthcare Market by Treatment (Immunotherapy, Medications, Surgeries), Indication (Asthma & Allergies, Cardiac Disorders, Genetic Disorders), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 188 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968855
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Paediatric Healthcare Market size was estimated at USD 107.01 billion in 2023, USD 114.55 billion in 2024, and is expected to grow at a CAGR of 7.53% to reach USD 177.94 billion by 2030.

Pediatric healthcare is a branch of medicine pertaining to the provision of medical care to infants, children, and adolescents. The age range typically considered for pediatric care is from birth up to 18 years. This field of healthcare encompasses a wide range of services, including prophylactic health care for healthy children and medical care for those who are acutely and chronically ill. Growing awareness among child parents of the need for adequate treatment, supported by rising government support and initiatives to promote pediatric health, has significantly contributed to the growth of the market. In addition, increasing investments in research & development for pediatric-specific medical devices and pharmaceuticals have a positive impact on market expansion. Despite the growth, the market faces several challenges, including high costs associated with pediatric care and specialty drugs, a shortfall in pediatric healthcare professionals, and uneven access to healthcare services across different regions. Regulatory hurdles for the approval of pediatric pharmaceuticals and devices also constitute significant limitations, as does the complexity of managing diverse health issues in a pediatric population. Technological advancements in neonatal and pediatric care equipment create lucrative opportunities for market growth. Additionally, the market sees potential in expanding access through telehealth services tailored for children and in integrating AI and machine learning to improve pediatric diagnostic and treatment protocols.

Regional Insights

In the American region, pediatric healthcare is characterized by a combination of private and public funding, with an emphasis on innovation in treatment and drug development. Consumer needs are heavily influenced by the availability of advanced healthcare infrastructure and a strong focus on preventive care. Customer purchasing behavior leans towards providers that offer comprehensive services and holistic care. Investments in pediatric research are significant, with initiatives often funded through public-private partnerships. The European Union presents a diverse healthcare landscape with varying levels of access and quality. The common trend towards equitable healthcare systems is built on universal coverage. Consumer needs in pediatric healthcare focus on integrative services that address both the physiological and psychological aspects of child development. Emerging research within EU countries often explores the efficacy of pediatric treatments and health system improvements. The European Commission supports several research initiatives and collaborations aimed at enhancing pediatric healthcare. The APAC market is rapidly growing, with government policies favoring expanded coverage and improved healthcare access for children. Countries including China, India, and Japan are seeing significant research investment, particularly in the development of pediatric drugs and vaccines.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Paediatric Healthcare Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Paediatric Healthcare Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Paediatric Healthcare Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca PLC, Aveanna Healthcare, LLC., Becton, Dickinson and Company, bioMérieux SA, Boehringer Ingelheim International GmbH, Eisai Co., Ltd., Eli Lilly and Company, Enviva Inc., Gilead Sciences, Inc., Glaxosmithkline PLC, GP Pharm, S.A., Henin Lukinz Pvt. Ltd., Interim HealthCare Inc., Janssen Global Services LLC, Johnson & Johnson Services, Inc., Medexus Pharmaceuticals, Inc., Medtronic PLC, Merck KGaA, Novartis AG, Olympus Corporation, ORPHELIA Pharma, Pfizer Inc., Proveca Ltd., Royal Philips, Sanofi S.A, Siemens AG, Strykar Corporation, The Procter & Gamble Company, Thermo Fisher Scientific, Inc., and Viatris Inc.

Market Segmentation & Coverage

This research report categorizes the Paediatric Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Treatment
    • Immunotherapy
    • Medications
    • Surgeries
  • Indication
    • Asthma & Allergies
    • Cardiac Disorders
    • Genetic Disorders
    • Metabolic Disorders
  • End-User
    • Ambulatory Care Centers
    • Homecare Settings
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Paediatric Healthcare Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Paediatric Healthcare Market?
  3. What are the technology trends and regulatory frameworks in the Paediatric Healthcare Market?
  4. What is the market share of the leading vendors in the Paediatric Healthcare Market?
  5. Which modes and strategic moves are suitable for entering the Paediatric Healthcare Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Paediatric Healthcare Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing number of deaths attributed to viral infections and malnutrition
5.1.1.2. Rising government support and initiatives to promote pediatric health
5.1.1.3. Growing awareness among child parents for adequate treatment
5.1.2. Restraints
5.1.2.1. Ethical concerns and small size of the study population
5.1.3. Opportunities
5.1.3.1. Growing research and development in technological advancements
5.1.3.2. Surge in medical expenditure in emerging economies
5.1.4. Challenges
5.1.4.1. Lack of pediatricians across the globe
5.2. Market Segmentation Analysis
5.2.1. Treatment: Expanding usage of pediatric healthcare for immunotherapy for a myriad of health conditions
5.2.2. Indication: Growing need for effective, age-appropriate medications in pediatric healthcare to manage asthma & allergies
5.2.3. End-User: Growing usage of pediatric healthcare across hospitals & clinics that offer a wide range of services
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Paediatric Healthcare Market, by Treatment
6.1. Introduction
6.2. Immunotherapy
6.3. Medications
6.4. Surgeries
7. Paediatric Healthcare Market, by Indication
7.1. Introduction
7.2. Asthma & Allergies
7.3. Cardiac Disorders
7.4. Genetic Disorders
7.5. Metabolic Disorders
8. Paediatric Healthcare Market, by End-User
8.1. Introduction
8.2. Ambulatory Care Centers
8.3. Homecare Settings
8.4. Hospitals & Clinics
9. Americas Paediatric Healthcare Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Paediatric Healthcare Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Paediatric Healthcare Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Merger & Acquisition
12.3.1.1. Cortica Closes USD 75 Million in New Funding Round and Acquires Springtide Child Development
12.3.1.2. Ipsen to Acquire Albireo Accelerating Growth in Rare Disease with Treatments for Several Pediatric Liver Diseases
12.3.2. Investment & Funding
12.3.2.1. Pediatric Behavioral Health Provider Bend Health Moves Out of Stealth Mode with USD 32M in Funding
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. AstraZeneca PLC
13.1.3. Aveanna Healthcare, LLC.
13.1.4. Becton, Dickinson and Company
13.1.5. bioMérieux SA
13.1.6. Boehringer Ingelheim International GmbH
13.1.7. Eisai Co., Ltd.
13.1.8. Eli Lilly and Company
13.1.9. Enviva Inc.
13.1.10. Gilead Sciences, Inc.
13.1.11. Glaxosmithkline PLC
13.1.12. GP Pharm, S.A.
13.1.13. Henin Lukinz Pvt. Ltd.
13.1.14. Interim HealthCare Inc.
13.1.15. Janssen Global Services LLC
13.1.16. Johnson & Johnson Services, Inc.
13.1.17. Medexus Pharmaceuticals, Inc.
13.1.18. Medtronic PLC
13.1.19. Merck KGaA
13.1.20. Novartis AG
13.1.21. Olympus Corporation
13.1.22. ORPHELIA Pharma
13.1.23. Pfizer Inc.
13.1.24. Proveca Ltd.
13.1.25. Royal Philips
13.1.26. Sanofi S.A
13.1.27. Siemens AG
13.1.28. Strykar Corporation
13.1.29. The Procter & Gamble Company
13.1.30. Thermo Fisher Scientific, Inc.
13.1.31. Viatris Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. PAEDIATRIC HEALTHCARE MARKET RESEARCH PROCESS
FIGURE 2. PAEDIATRIC HEALTHCARE MARKET SIZE, 2023 VS 2030
FIGURE 3. PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PAEDIATRIC HEALTHCARE MARKET DYNAMICS
FIGURE 7. PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 8. PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PAEDIATRIC HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. PAEDIATRIC HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. PAEDIATRIC HEALTHCARE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. PAEDIATRIC HEALTHCARE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PAEDIATRIC HEALTHCARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 6. PAEDIATRIC HEALTHCARE MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PAEDIATRIC HEALTHCARE MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PAEDIATRIC HEALTHCARE MARKET SIZE, BY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 10. PAEDIATRIC HEALTHCARE MARKET SIZE, BY ASTHMA & ALLERGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PAEDIATRIC HEALTHCARE MARKET SIZE, BY CARDIAC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PAEDIATRIC HEALTHCARE MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PAEDIATRIC HEALTHCARE MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 15. PAEDIATRIC HEALTHCARE MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. PAEDIATRIC HEALTHCARE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 29. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 30. CANADA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 32. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 33. MEXICO PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. CHINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 46. CHINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 47. CHINA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. INDIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 49. INDIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 50. INDIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. JAPAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 55. JAPAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 56. JAPAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. THAILAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 73. THAILAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 74. THAILAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. DENMARK PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 83. DENMARK PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 84. DENMARK PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. EGYPT PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 86. EGYPT PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 87. EGYPT PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. FINLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 89. FINLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. FINLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. FRANCE PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 92. FRANCE PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. FRANCE PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. GERMANY PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 95. GERMANY PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 96. GERMANY PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. ITALY PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 101. ITALY PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 102. ITALY PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. NORWAY PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 110. NORWAY PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 111. NORWAY PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. POLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 113. POLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 114. POLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. QATAR PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 116. QATAR PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 117. QATAR PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. SPAIN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 128. SPAIN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 129. SPAIN PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. TURKEY PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 137. TURKEY PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 138. TURKEY PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM PAEDIATRIC HEALTHCARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. PAEDIATRIC HEALTHCARE MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 146. PAEDIATRIC HEALTHCARE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 147. PAEDIATRIC HEALTHCARE MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • AstraZeneca PLC
  • Aveanna Healthcare, LLC.
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Boehringer Ingelheim International GmbH
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Enviva Inc.
  • Gilead Sciences, Inc.
  • Glaxosmithkline PLC
  • GP Pharm, S.A.
  • Henin Lukinz Pvt. Ltd.
  • Interim HealthCare Inc.
  • Janssen Global Services LLC
  • Johnson & Johnson Services, Inc.
  • Medexus Pharmaceuticals, Inc.
  • Medtronic PLC
  • Merck KGaA
  • Novartis AG
  • Olympus Corporation
  • ORPHELIA Pharma
  • Pfizer Inc.
  • Proveca Ltd.
  • Royal Philips
  • Sanofi S.A
  • Siemens AG
  • Strykar Corporation
  • The Procter & Gamble Company
  • Thermo Fisher Scientific, Inc.
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information